| ABC | ATP-binding cassette |
| ABCB1 | ATP-binding cassette, subfamily B (MDR/TAP), member 1 |
| ABCC2 | ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
| ABCC3 | ATP-binding cassette, subfamily C (CFTR/MRP), member 3 |
| ABCC5 | ATP-binding cassette, subfamily C (CFTR/MRP), member 5 |
| ACT | anthracycline-induced cardiotoxicity |
| ACYP2 | acylphosphatase 2 |
| ADME | absorption, distribution, metabolism, excretion |
| AKT | AKT serine/threonine kinase |
| ALT | alanine transaminase |
| ATM | ataxia telangiectasia mutated) |
| ATR | ataxia telangiectasia and Rad3 related |
| ATRX | ATRX chromatin remodeler |
| AURKB | Aurora kinase B |
| B-Raf | B-Raf proto-oncogene, serine/threonine kinase |
| BRCA1 | breast related cancer antigen 1 |
| BRCA 2 | breast related cancer antigen 2 |
| Cas9 | CRISPR associated protein 9 |
| CBRs | carbonyl reductases |
| CCNE1 | cyclin E1 |
| CDK4 | cyclin-dependent kinase 4 |
| CDK6 | cyclin-dependent kinase 6 |
| CDKN2A | cyclin dependent kinase inhibitor 2A |
| CHST12 | carbohydrate sulfotransferase 12 |
| CI | confidence interval |
| CN | copy number |
| COMT | catechol O-methyltransferase |
| COSMIC | catalogue of somatic mutations in cancer |
| COX8A | cytochrome C oxidase subunit 8A |
| CRISPR | clustered regularly interspaced palindromic repeats |
| CTLA-4 | cytotoxic T-lymphocyte antigen 4 |
| CYP | cytochrome P450 |
| DHFR | dihydrofolate reductase |
| DMEs | drug metabolizing enzymes |
| ERCC 1 | excision repair cross-complementation group 1 |
| ERCC 2 | excision repair cross-complementation group 2 |
| ERCC 5 | excision repair cross-complementation group 5 |
| ERK | extracellular signal-regulated kinase |
| EZH1 | enhancer of zeste 1 polycomb repressive complex 2 subunit |
| EZH2 | enhancer of zeste 2 polycomb repressive complex 2 subunit |
| FGFR | fibroblast growth factor receptor |
| GATA1 | GATA binding protein 1 |
| GGH | gamma-glutamyl hydrolase |
| GRM4 | glutamate metabotropic receptor 4 |
| GST | glutathione S-transferase |
| GSTM1 | glutathione S-transferase M1 |
| GSTM3 | glutathione S-transferase M3 |
| GSTP1 | glutathione S-transferase P1 |
| GSTT1 | glutathione S-transferase T1 |
| GWAS | genome-wide association study |
| HAS3 | hyaluron synthase 3 |
| HGOS | high-grade osteosarcoma |
| IL-8 | interleukin-8 |
| INFORM | INdividualized therapy FOr Relapsed Malignancies |
| lncRNAs | long non-coding RNAs |
| LP | likely pathogenic |
| LRP2 | LDL receptor related protein 2, or megalin |
| MAPK | mitogen-activated protein kinase |
| MDM2 | mouse double minute 2 (also known as murine double minute 2) |
| MDM4 | mouse double minute 4 |
| MEN1 | menin 1 |
| miRNAs | microRNAs |
| MMS19 | nucleotide excision repair homolog |
| MSH2 | mutS homolog 2 |
| MTHFD1 | methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 |
| MTHFR | methylenetetrahydrofolate reductase |
| mTOR | mammalian target of rapamycin (mechanistic target of rapamycin) |
| MTX | methotrexate |
| NBN | nibrin |
| NER | nucleotide excision repair |
| NF1 | neurofibromin 1 |
| NFE | non-Finish European |
| NGS | next generation sequencing |
| NSG | NOD Scid gamma |
| odd ratio | OR |
| P | pathogenic |
| PARP1 | poly (ADP-ribose) polymerase 1 |
| PD-1 | programmed cell death-1 |
| PD-L1 | programmed death-ligand 1 |
| PDXs or PDTXs | patient-derived tumor xenografts |
| PI3K | phosphatidylinositol 3 kinase |
| PMS2 | PMS1 homolog 2, mismatch repair system component |
| POT1 | protection of telomeres 1 |
| PRCKG | protein kinase CGMP-dependent 1 |
| PTEN | phosphatase and tensin homolog |
| RAD21 | RAD21 cohesin complex component |
| RARG | retinoic acid receptorγ |
| RB1 | RB transcriptional corepressor 1 (also known as retinoblastoma gene 1) |
| RECQL2 | RecQ like helicase 2 |
| RECQL3 | RecQ like helicase 3 |
| RECQL4 | RecQ like helicase 4 |
| RECQL5 | RecQ like helicase 5 |
| RFC | reduced folate carrier |
| RPS19 | ribosomal protein S19 |
| RPS26 | ribosomal protein S26 |
| RUNX1 | RUNX family transcription factor 1 |
| SATB2 | SATB homeobox 2 |
| SCNAs | somatic copy number aberrations |
| SLC19A1 | solute carrier family 19 (folate transporter) member 1 (also known as reduced folate carrier, RFC or reduced folate carrier 1, RFC1) |
| SLC22A17 | solute carrier family 22 member 17 |
| SLC22A2 | solute carrier family 22 member 2 |
| SLC22A7 | solute carrier family 22 member 7 |
| SLC22A8 | solute carrier family 22 member 8 |
| SLC28A3 | solute carrier family 28 member 3 |
| SLCO1B1 | solute carrier organic anion transporter family member 1B1 |
| SMARCA4 | SWI/SNF related matrix associated actin dependent regulator of chromatin, subfamily A, member 4 |
| SMARCB1 | SWI/SNF related matrix associated actin dependent regulator of chromatin, subfamily B, member 1 |
| SNPs | single nucleotide polymorphisms |
| SNV | somatic nucleotide variants |
| SV | structural variations |
| TARGET | Therapeutically Applicable Research to Generate Effective Treatments |
| TGFB1 | transforming growth factor beta 1 |
| TMB | tumor mutational burden |
| TNF | tumor necrosis factor |
| TP53 | tumor protein 53 |
| TPMT | thiopurine S-methyltransferase |
| TS | thymidylate synthase |
| TSC | TSC complex subunit |
| UGT1A6 | UDP glucuronosyltransferase 1 A6 |
| UGT2B15 | UDP glucuronosyltransferase family 2 member B15 |
| VEGF | vascular endothelial growth factor |
| VHL | Von Hippel-Lindau tumor suppressor |
| WES | whole-exome sequencing |
| WGS | whole-genome sequencing |
| XPC | xeroderma pigmentosum complementation group C |
| XRCC3 | X-ray repair cross complementing 3 |